Notice: This company has been marked as potentially delisted and may not be actively trading. resTORbio (TORC) News Today Add Compare Share Share Headlines Stock AnalysisCompetitorsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Adicet Bio Inc (ACET)January 30, 2024 | investing.comMichelle Chaka Joins Torc as Senior Vice President, Safety and RegulatoryFebruary 24, 2023 | finance.yahoo.comTinOne Resources Inc. (TORC.V)January 10, 2023 | finance.yahoo.comCelebrity Strategy Consultant Predicts What Will Be The Most Impactful Area In The Pharmaceutical Industry - ForbesSeptember 19, 2022 | forbes.comFast-growing cancer cell therapy developer Adicet Bio takes more space - San Francisco Business Times - The Business JournalsSeptember 12, 2022 | bizjournals.comForm DEF 14A BiomX Inc. For: Aug 24 - StreetInsider.comJuly 8, 2022 | streetinsider.comTerns Pharmaceuticals Appoints Kerry Russell as Chief Medical Officer - GuruFocus.comJune 21, 2022 | gurufocus.comTerns Pharmaceuticals Inc. (TERN) Appoints Kerry Russell as Chief Medical Officer - StreetInsider.comJune 1, 2022 | streetinsider.comTerns Pharmaceuticals Appoints Kerry Russell as Chief Medical Officer - StreetInsider.comJune 1, 2022 | streetinsider.comTerns Pharmaceuticals Appoints Kerry Russell as Chief Medical Officer - GlobeNewswireJune 1, 2022 | globenewswire.comPureTech Announces Annual Results for Year Ended December 31, 2021 - StreetInsider.comApril 27, 2022 | streetinsider.comPureTech Announces Annual Results for Year Ended December 31, 2021 - Business WireApril 26, 2022 | businesswire.com$3.68 Billion Worldwide Cellular Immunotherapy Industry to 2031 - Identify Growth Segments for Investment - ResearchAndMarkets.com - Business WireMarch 21, 2022 | businesswire.comADICET BIO, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K) - Marketscreener.comMarch 15, 2022 | marketscreener.comAdicet Bio: Gamma Delta 1 CAR-T Technology And A Takeover Candidate - Seeking AlphaFebruary 8, 2022 | seekingalpha.comCan The Pharmaceutical Companies Use Basic Aging Biology To Develop Drugs For Age-Related Diseases? - ForbesJanuary 3, 2022 | forbes.comAdicet soars on early clinical data for cancer cell therapy - San Francisco Business Times - San Francisco Business TimesDecember 9, 2021 | bizjournals.comADICET BIO, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) - marketscreener.comNovember 11, 2021 | marketscreener.comADICET BIO, INC. : Termination of a Material Definitive Agreement (form 8-K) - marketscreener.comOctober 30, 2021 | marketscreener.comNasdaq’s ConnectIR Surpasses 10,000 Bookings as Activity Surges Amid Pandemic - NasdaqOctober 20, 2021 | nasdaq.comGlobal Cellular Immunotherapy Market research Report 2021: Companies are Focusing on Developing Off-the-Shelf Allogeneic Therapies for New and Improved Cancer Treatment - PRNewswireAugust 12, 2021 | prnewswire.comOyster Point Pharma Announces New Chairperson Appointment to Board of Directors - StreetInsider.comAugust 3, 2021 | streetinsider.comOyster Point Pharma Inc. (OYST) Appoints Donald Santel to its Board - StreetInsider.comAugust 3, 2021 | streetinsider.comOyster Point Pharma Announces New Chairperson Appointment to Board of Directors - Yahoo FinanceAugust 2, 2021 | finance.yahoo.com Get resTORbio News Delivered to You Automatically Sign up to receive the latest news and ratings for TORC and its competitors with MarketBeat's FREE daily newsletter. Email Address Download Our Tesla Ebook For Free (Ad)Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost. To claim your copy free of charge simply follow this link. TORC Media Mentions By Week TORC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TORC News Sentiment▼0.000.47▲Average Medical News Sentiment TORC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TORC Articles This Week▼00▲TORC Articles Average Week Get resTORbio News Delivered to You Automatically Sign up to receive the latest news and ratings for TORC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PepGen News Sagimet Biosciences News Inventiva News Incannex Healthcare News Telomir Pharmaceuticals News Skye Bioscience News Repare Therapeutics News Seres Therapeutics News Pyxis Oncology News Ventyx Biosciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TORC) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding resTORbio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share resTORbio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.